Table 2.
Pancreatic adenocarcinoma Incidence-based mortality rates (1973-2014)
| characteristic | Incidence-based mortality of pancreatic adenocarcinoma | Incidence-based mortality of adenocarcinoma of the head of pancreas | Incidence-based mortality of adenocarcinoma of the body and tail of pancreas | |||
|---|---|---|---|---|---|---|
| Cases, No (%)a,b | Rate (95% CI)c | Cases, No (%)a,b | Rate (95% CI) c | Cases, No (%)a,b | Rate (95% CI) c | |
| Overall | 63,426 (100) | 6.52 (6.47 - 6.57) | 31,609 (100) | 3.26 (3.22 - 3.30) | 12,859 (100) | 1.32 (1.29 - 1.39) |
| Sex | ||||||
| Male | 32,771 (51.67) | 7.73 (7.65 - 7.82) | 15,975 (50.54) | 3.79 (3.73 - 3.86) | 6,903 (53.68) | 1.61 (1.57 - 1.65) |
| Female | 30,655 (48.33) | 5.58 (5.52 - 5.64) | 15,634 (49.46) | 2.84 (2.79 - 2.89) | 5,956 (46.32) | 1.09 (1.06 - 1.11) |
| Race | ||||||
| White | 51,742 (81.58) | 6.36 (6.30 - 6.41) | 25,815 (81.67) | 3.18 (3.14 - 3.22) | 10,289 (80.01) | 1.26 (1.24 - 1.28) |
| Black | 7,309 (11.52) | 9.42 (9.19 - 9.64) | 3,736 (11.82) | 4.84 (4.68 – 5.00) | 1,557 (12.11) | 1.99 (1.89 - 2.09) |
| Othersd | 4,313 (6.80) | 5.34 (5.18 - 5.50) | 2,030 (6.42) | 2.52 (2.41 - 2.64) | 997 (7.75) | 1.22 (1.15 - 1.30) |
| Unknowne | 62 (0.10) | - | 28 (0.09) | - | 16 (0.13) | - |
| Age at death, y | ||||||
| <60 | 13,432 (21.18) | 1.59 (1.56 - 1.62) | 6,358 (20.11) | 0.75 (0.73 - 0.77) | 2,869 (22.31) | 0.34 (0.33 - 0.35) |
| >60 | 49,994 (78.82) | 31.45 (31.16 - 31.73) | 25,251 (79.89) | 15.93 (15.73 - 16.13) | 9,990 (77.69) | 6.25 (6.13 - 6.38) |
| Statef | ||||||
| California | 10,192 (16.07) | 6.60 (6.47 - 6.73) | 5,196 (16.44) | 3.38 (3.29 - 3.47) | 2,092 (16.27) | 1.35 (1.29 - 1.41) |
| Connecticut | 10,146 (16.00) | 6.90 (6.76 - 7.03) | 4,991 (15.79) | 3.39 (3.30 - 3.49) | 2,077 (16.15) | 1.41 (1.35 - 1.47) |
| Georgia | 4,635 (7.30) | 6.57 (6.38 - 6.77) | 2,362 (7.47) | 3.38 (3.24 - 3.52) | 1,012 (7.87) | 1.41 (1.33 - 1.51) |
| Hawaii | 2,776 (4.38) | 6.11 (5.88 - 6.34) | 1,245 (3.94) | 2.75 (2.60 - 2.91) | 631 (4.91) | 1.38 (1.27 - 1.49) |
| Iowa | 8,556 (13.49) | 6.31 (6.17 - 6.44) | 4,383 (13.87) | 3.22 (3.12 - 3.32) | 1,767 (13.74) | 1.31 (1.25-1.37) |
| Michigan | 11,916 (18.79) | 7.52 (7.38 - 7.66) | 5,882 (18.61) | 3.73 (3.63 - 3.82) | 2,350 (18.27) | 1.48 (1.42 -1.54) |
| New Mexico | 3,660 (5.77) | 5.77 (5.59 - 5.97) | 1,817 (5.75) | 2.86 (2.73 - 3.00) | 613 (4.77) | 0.96 (0.88 - 1.04) |
| Utah | 2,948 (4.65) | 4.99 (4.81 - 5.17) | 1,471 (4.65) | 2.51 (2.38 - 2.64) | 591 (4.60) | 0.99 (0.91 -1.07) |
| Washington | 8,597 (13.55) | 6.25 (6.12 - 6.38) | 4,262 (13.48) | 3.11 (3.02 - 3.21) | 1,726 (13.42) | 1.25 (1.19-1.31) |
| Stage at diagnosisg | ||||||
| Localized | 4,656 (7.34) | 0.49 (0.47 - 0.50) | 3,250 (10.28) | 0.34 (0.33 - 0.35) | 610 (4.74) | 0.06 (0.06 - 0.07) |
| Regional | 16,977 (26.77) | 1.75 (1.72- 1.78) | 12,083 (38.23) | 1.25 (1.22 - 1.27) | 1,878 (14.60) | 0.19 (0.18 - 0.20) |
| Distant | 37,327 (58.85) | 3.81 (3.78 - 3.85) | 14,170 (44.83) | 1.45 (1.42 - 1.47) | 9,929 (77.21) | 1.01 (0.99 - 1.03) |
| Unstaged | 4,466 (7.04) | 0.47 (0.46-0.48) | 2,106 (6.66) | 0.22 (0.21-0.23) | 442 (3.45) | 0.05 (0.04-0.05) |
aCases included first primary tumors that matched the selection criteria, were microscopically confirmed, and were not identified only from autopsy records or death certificates
bNo. (%) of deaths were based on cases diagnosed during 1973-2014
cRates were calculated as number of deaths per 100 000 person-years and age adjusted to the 2000 US standard population
dIncludes American Indian/Alaskan Native and Asian/Pacific Islander
eRates for patients with unknown race could not be calculated, as ‘race’ is a population variable and must be known to calculate rates
fRates were calculated between 1973-2014 for all states except Georgia; 1975-2014, and Washington; 1974-2014
gUsing SEER historic stage A